Coriell Life Sciences:

Bridging the Gap Between Genetic Science and Clinical Application

Coriell Life Sciences (CLS) is the commercial venture of the world-renowned Coriell Institute for Medical Research, a non-profit biomedical research institution, founded in 1953, dedicated to studying the human genome.In 2007, the Institute launched the Coriell Personalized Medicine Collaborative (CPMC), a research study seeking to understand the value of genetic risk and pharmacogenomics in clinical decision-making and healthcare management. The results of that study led to the founding of Coriell Life Sciences in 2013.

Today, CLS is a trusted provider of genetic laboratory interpretation and reporting services. We offer the most comprehensive medication safety solution on the market. We also provide precise, gene-based diagnostic reporting.  We’re leveraging the power of genomics to bring the best available information to physicians and their patients.